Neuropathic Pain Intervention With tDCS in Brazilian Military Personnel (NeuBRAIN Trial)
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorHospital da Polícia Militar de Goiás
About this trial
This project protocol investigates the efficacy of transcranial direct current stimulation (tDCS) in treating neuropathic pain and improving sleep quality among Brazilian military personnel. Given the high prevalence of chronic pain and sleep disturbances in this population, and the limitations of current pharmacological treatments, our randomized, triple-blinded, sham-controlled trial explores the potential of tDCS as a non-invasive therapeutic intervention. The results of this study could have a significant impact on improving the well-being and performance of military personnel, while also reducing healthcare costs associated with long-term medication use.
Eligibility criteria
Qualifiers
Military personnel (active and veterans) with chronic pain due to central or peripheral neuropathy and poor sleep quality;
Age over 18 years old;
Defined chronic NeP according to current guidelines (ICD-10 codes OR DN-4);
Pain with an average intensity score above 40/100 mm on a visual analogue scale (VAS);
Disqualifiers
General contraindications for tDCS: past head trauma, current epilepsy, intracranial ferromagnetic components, pacemaker, implanted microprocessors (i.e., cochlear implants);
Pregnancy;
Known major psychiatric disorders (as assessed by the DSM-5, e.g., psychosis), history of substance abuse, or work litigation issues;
History of chronic refractory migraines;
Trial design
Treatments tested in this trial
- tDCS
- sham intervention
Treatment groups
120 Participants
are divided into 3 treatment groupsSponsors and collaborators
Hospital da Polícia Militar de Goiás
Lead sponsor
Hospital das Clínicas de São Paulo - SP
Collaborator
Source ClinicalTrials.gov